CHUGAI PHARMACEUTICAL CO., LTD.
4519・Prime Market・Pharmaceuticals
CHUGAI PHARMACEUTICAL CO., LTD.4519
Recent Disclosures
| Date | Type | Title |
|---|---|---|
| 2026-04-24 | Other | CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited)(for the three months ended March 31, 2026) |
| 2026-04-24 | Other | Supplementary Materials Consolidated Financial Statements for the three months ended March 31, 2026 (IFRS) |
| 2026-04-24 | Other | Determination of Details Regarding Share Acquisition Associated with the Introduction of the Trust-Based Stock Compensation System |
| 2026-04-24 | Other | 信託型株式報酬制度の導入に伴う株式取得の詳細決定に関するお知らせ |
| 2026-04-24 | Other | 2026年12月期第1四半期連結決算〔IFRS〕 補足資料 |
| 2026-04-24 | Earnings Report | 2026年12月期第１四半期決算短信〔ＩＦＲＳ〕（連結） |
| 2026-04-23 | Other | エフ・ホフマン・ラ・ロシュの 2026 年第 1 四半期の販売実績について |
| 2026-04-23 | Other | F. Hoffmann-La Roche Announces First Quarter Sales 2026 |
| 2026-04-01 | Other | Corporate Governance Report |
| 2026-04-01 | Other | コーポレート・ガバナンスに関する報告書 2026/04/01 |